Lipitor Gains New Indications For Patients With Established Heart Disease
FDA approves Pfizer’s atorvastatin for five new indications based on the results of the Treating to New Targets trial.
FDA approves Pfizer’s atorvastatin for five new indications based on the results of the Treating to New Targets trial.